There are a lot of other avenues other than the USA that’s ave...

There are a lot of other avenues other than the USA that’s ave the potential to be a game changer also all IMO

The Microsoft story will put this on the radar of big data investors as well as AI institutions

The NHS trial in the UK could be huge.

Further adoption across regional screening programmes in NZ has high potential.

Further uptake in the USA - 3% last year and on track for 9% this year. That’s is great market penetration in a year.

The churn is the number I’m watching. This to me is an indication of how much technicians can’t do without the service. If this stays low - while maker penetration increases what will the SP be at 25% of the USA market? Will this put VHT with an ARR on circa $20M per year as a SAS company. When will that happen. I believe within 3 years.

What market penetration number will this product start selling itself? I believe 25% is this number at which it becomes the new normal

LT hold for me. However the shares are tightly held. I see liquidity being an issue. The price has the potential to swing as it always has, until such a time where price appreciates and liquidity takes care of itself